By inhibiting PARP enzymes involved in DNA repair, particularly in cells with homologous recombination repair deficiency (HRD), PARPis induce tumor cell death through synthetic lethality (20). Here, PARP1 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.